Bas van Rhijn

Before I started working as an oncological urologist at the Netherlands Cancer Institute at the end of 2010, I followed my training in Nijmegen, Delft, Rotterdam and Toronto (Canada). In 2005 I obtained my PhD laude in Rotterdam with the thesis "Molecular diagnosis and prognosis of bladder cancer". After training as a urologist in the Netherlands, I did a uro-oncology fellowship of 2.5 years in Toronto (Canada) supported by the Dutch Cancer Society. Since 2016, I have also been affiliated with the University of Regensburg (Germany), where I obtained my PhD for the second time in 2020 with the thesis "Clinical, histo-pathological and translational aspects associated with bladder cancer prognosis". In 2020, the appointments as "Associate Professor" and "Private Lecturer" at that University also followed.      

My clinical areas of interest are bladder cancer, upper urinary tract cancer, penile cancer, testicular cancer and urachus cancer. For all these types of cancer, the Netherlands Cancer Institute is a national centre of expertise with an international presence in which there is close cooperation between various medical and nursing specialists within radiotherapy, oncology, plastic surgery, radiology, nuclear medicine and pathology. Patients can visit our various rapid diagnostics outpatient clinics every week and together we have a multidisciplinary consultation (MDO) every week. This ensures that every patient receives tailor-made care, where all treatment options are considered and can be offered at the Netherlands Cancer Institute. As a centre of expertise, we also pay attention to the quality of life before and after the (often drastic treatment for the patient). To this end, we work together with our Centre for Quality of Life and with the patient platform 'rare cancers'.

Since 2017 I have been a urology trainer and vice-chairman of the central education committee (COC) of the Netherlands Cancer Institute. As a urology trainer, I am responsible for the ins and outs of the fellow (young urologist) and urology assistants in training (almost urologist). Within the COC, the quality of all courses in the NKI-AVL is guaranteed. In 2019 I won the "Trainer of the Year" award from the Netherlands Cancer Institute. 

Innovation through scientific research is the way to advance a profession. With various specialists and researchers from the NKI-NKI, the University of Regensburg and several International Consortia, I work on various aspects of bladder and urachus cancer research. Three research fellows from France, Switzerland and Italy did their internship with me at the NKI. I also supervised three medical students with their graduation thesis. I also enjoy supervising PhD students with their scientific research. Four of them successfully defended their dissertations and have therefore obtained their PhDs. At the moment (early 2023), eight of my PhD students are still working on making their research a success.   

Oncological care at an academic level with short lines of communication and always focused on patients, education and research; That is why I see the Netherlands Cancer Institute as the ideal place to continue to contribute to this, both clinically and scientifically.

Function:

Urologist and Urology Trainer.

Positions and areas of interest:

• Urology trainer and vice-chairman of the central training committee AVL
• Member of the plenary visitation committee of the RGS for the urology training
• Medical advisor urachus cancer for the patient platform Rare Cancers
• Member of focus groups bladder, penis and testicular cancer Antoni van Leeuwenhoek
• Member of the European (EAU) guidelines committees of Bladder Cancer and Upper Urinary Tract Cancer
• Associate Editor of scientific journal "Bladder Cancer"
• Member of the Editorial Board of scientific journals "European Urology" and "European Urology Open Science"

Qualifications:

• 2005: PhD (laude) in the field of bladder cancer, Erasmus University, Rotterdam
• 2008: Fellow of the European Board of Urology (FEBU), European Board of Urology
• 2010: Fellow of the Society of Urologic Oncology (CISA), American Urological Association
• 2020: PhD in the field of bladder cancer, University of Regensburg (Germany)

Praise:

2019: Trainer of the Year 2019 in NKI-AVL, Amsterdam
2009: Young Investigator Research Award Canadian Urology Research Consortium (CURC) and Canadian Urological Oncology Group (CUOG)
2009 & 2010: First prize Basic Science Charles J. Robson Day. Division of Urology, University of Toronto
2006: Thesis Award of the European Association of Urology (EAU) for the thesis: "Molecular Diagnosis and Prognosis of Bladder Cancer"
2004: Prof. Moonen Prize of the Dutch Society for Urology for research into molecular aspects of bladder cancer
2001: Vlietstra Prize of the Dutch Society for Urology for the lecture: "FGFR3 Mutations Occur Very Frequently in Bladder Tumors and Identify Patients with Favorable Clinical Parameters"

Scientific publications:

Publication list (PubMed) of B.W.G. van Rhijn
H-index and citations of research by B.W.G. van Rhijn